-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Ramucirumab: a promising development in advanced non-small cell lung cancer
Virginie Avrillon & Maurice Perol
Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term extension trials to prove the efficacy and safety of bisphosphonates
Paul D Miller
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
Talya Waldman, Chrisandra L Shufelt, Glenn D Braunstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 6
Acknowledgements: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Eva Baroke, Shyam Maharaj, Martin Kolb
Review Article: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation